Hong Kong Insurance Stock News

For investors wondering whether BYD at about HK$103.50 is a bargain or just fairly priced right now, this article walks through what the current numbers indicate about value. Recent returns have been mixed, with the stock down about 8.6% over the past week and 3.3% over the past month, while the year-to-date return sits at 4.8% and the 1-year return at a 19.6% decline. Over a longer stretch, BYD shares show a 35.7% gain across 3 years and a 90.0% gain across 5 years. Recent weakness...

As global markets react positively to geopolitical de-escalations, the Asian market is experiencing a cautiously optimistic sentiment. This environment presents an intriguing backdrop for exploring penny stocks, which, despite their somewhat outdated label, continue to offer potential value through smaller or newer companies. By focusing on those with robust financials and clear growth trajectories, investors may find promising opportunities in these under-the-radar stocks that could offer...

From what we can see, insiders were net buyers in Galaxy Entertainment Group Limited's ( HKG:27 ) during the past 12...

Soft earnings didn't appear to concern Onewo Inc.'s ( HKG:2602 ) shareholders over the last week. Our analysis suggests...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...

The market for Shanghai Industrial Holdings Limited's ( HKG:363 ) shares didn't move much after it posted weak earnings...

As you might know, China Mobile Limited ( HKG:941 ) just kicked off its latest first-quarter results with some very...

GHW International's ( HKG:9933 ) stock didn't jump after it announced some healthy earnings. We think that investors...

The subdued stock price reaction suggests that Transport International Holdings Limited's ( HKG:62 ) strong earnings...

Unsurprisingly, Tongguan Gold Group Limited's ( HKG:340 ) stock price was strong on the back of its healthy earnings...

Some XXF Group Holdings Limited ( HKG:2473 ) shareholders may be a little concerned to see that the CEO & Chairman of...

As global markets react positively to signs of de-escalation in the Middle East, Asian markets are also experiencing renewed investor interest. Penny stocks, a term that may seem outdated but still relevant, often refer to smaller or newer companies that can offer substantial growth potential at lower price points. By identifying those with strong financials and clear growth paths, investors can uncover hidden gems within this niche market segment.

Shareholders might have noticed that Pop Mart International Group Limited ( HKG:9992 ) filed its full-year result this...

Haidilao International Holding (SEHK:6862) has drawn fresh attention after its shares closed at HK$14.70, with recent returns showing mixed momentum over the past week, month and past three months. See our latest analysis for Haidilao International Holding. At the current share price of HK$14.70, the recent 1 month share price return of 8.07% and 3 month share price return of 7.84% contrast with a 1 year total shareholder return of 12.75% and 5 year total shareholder return of 66.24%,...

Leapmotor (SEHK:9863) has introduced the D19, described as the world's first premium SUV using a centralized QNX based software platform. The system integrates the digital cockpit, advanced driver assistance, and connectivity functions into a single safety certified domain. This launch marks the first mass produced vehicle to consolidate these core software defined features on advanced QNX platforms. For investors watching the electric vehicle space, this move puts software architecture at...

Sinopharm Group (SEHK:1099) opened 2026 with Q1 revenue of about CNY 17.8b and basic EPS of CNY 0.52, setting the tone against a trailing twelve month profile that shows revenue of roughly CNY 574.7b and EPS of CNY 2.28. Over recent quarters investors have seen quarterly revenue move from about CNY 141.7b in Q1 2025 to CNY 145.4b in Q3 2025 and CNY 143.7b in Q4 2025, with basic EPS ranging from CNY 0.47 to CNY 3.29 across that period as the business cycled through different earnings levels...

If you are looking at Cathay Pacific Airways and asking whether the current share price fairly reflects its prospects, the valuation story is where things get interesting. The stock last closed at HK$11.96, with returns of 1.2% over 7 days, a 0.5% decline over 30 days, a 5.3% decline year to date, 43.4% over 1 year, 90.9% over 3 years and 108.7% over 5 years. This performance may lead you to question whether the current price still offers value or has already priced in much of the recent...

As Asian markets navigate the complexities of geopolitical developments and economic data, investors are increasingly focused on identifying opportunities that may be undervalued by the broader market. In such an environment, a good stock is often characterized by strong fundamentals and resilience to external pressures, making it well-positioned to capitalize on potential market shifts.

Genscript Biotech (SEHK:1548) has proposed amendments to its memorandum and articles of association. The planned changes relate to the company’s core corporate governance framework and could influence shareholder rights and internal decision making. For investors watching Genscript Biotech at a share price of HK$14.19, the move to adjust its foundational documents comes alongside mixed longer term share performance. The stock is up 6.6% over the past week, 33.9% over the past month, 10.9%...

Those following along with EVA Precision Industrial Holdings Limited ( HKG:838 ) will no doubt be intrigued by the...

Despite posting some strong earnings, the market for Modern Living Investments Holdings Limited's ( HKG:8426 ) stock...

Lap Kei Engineering (Holdings) Limited's ( HKG:1690 ) healthy profit numbers didn't contain any surprises for...

South Manganese Investment Limited's ( HKG:1091 ) solid earnings announcement recently didn't do much to the stock...

Founder Holdings Limited's ( HKG:418 ) recent weak earnings report didn't cause a big stock movement. We think that...